The comparison of aripiprazole and risperidone augmentation in selective serotonin reuptake inhibitor-refractory obsessive-compulsive disorder: a single-blind, randomised study


Selvi Y., Atli A., Aydin A., Besiroglu L., Ozdemir P. , Ozdemir O.

HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, cilt.26, ss.51-57, 2011 (SCI İndekslerine Giren Dergi) identifier identifier identifier

  • Cilt numarası: 26 Konu: 1
  • Basım Tarihi: 2011
  • Doi Numarası: 10.1002/hup.1169
  • Dergi Adı: HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
  • Sayfa Sayıları: ss.51-57

Özet

Objective To investigate the comparative efficacy of aripiprazole and risperidone as augmenting agents in the treatment of obsessive-compulsive disorder (OCD) patients who did not show a >= 35% decrease in the Yale-Brown Obsessive-Compulsive Scale (Y-BOCS) after 12-week monotherapy with selective serotonin reuptake inhibitors (SSRIs).